About Bolt Med
Bolt Med is a Healthcare company based in Carlsbad (United States) founded in 2019 by Keegan Harper and Eric Schultheis, and was acquired by Boston Scientific in January 2025. Intravascular lithotripsy systems are developed for cardiovascular disease treatment. Its chief executive, as recorded, is Keegan Harper. Bolt Med offers products and services including Bolt IVL. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its competitors include Instylla, Jupiter Endovascular and Access Point Technologies; 2 of its 3 listed competitors have raised funding.
Company details
Bolt Medical was founded in 2019 and is headquartered in Carlsbad, United States. Operations center on the medical device sector, where laser-based intravascular lithotripsy catheters are designed and developed. These systems target coronary and peripheral interventional procedures for patients with moderate to severe calcified arterial disease. Focus remains on advancing treatments for cardiovascular conditions through specialized catheter technology.
- Headquarters Carlsbad, United States
- Founders Keegan Harper, Eric Schultheis
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website boltmed.com
- Social LinkedIn X
- Acquired by Boston Scientific (Jan 2025)
- Investors
- Acquired byBoston Scientific
(Jan 2025)
Products & Services of Bolt Med
Bolt Med offers a comprehensive portfolio of products and services, including Bolt IVL.
Laser-based system for fracturing calcium in blood vessels during procedures.
Investors in Bolt Med
Bolt Med has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Boston Scientific.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Wide range of medical devices | 1979 | bostonscientific.com | Marlborough, United States |
Investor details for Bolt Med
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Bolt Med
2 people are tracked at Bolt Med (2 in leadership).
| Name | Role | Group |
|---|---|---|
Keegan Harper | Co-Founder & CEO | Leadership |
Eric Schultheis | Co-Founder | Leadership |
Complete people profiles for Bolt Med
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Bolt Med
2 dated milestones of Bolt Med across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Bolt Med is founded.
- Exit Acquired by Boston Scientific.
Competitors of Bolt Med
Bolt Med has 3 listed competitors in our database, 2 of them funded. They include Instylla, Jupiter Endovascular and Access Point Technologies.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| instylla.com | 2017 | United States | $85.51M | 26 | Hydrogel technology is developed for embolization therapy applications. | |
| jupiterendo.com | 2024 | Menlo Park, United States | $61M | Minimally invasive medical devices for endovascular intervention are developed. | ||
| accesspointus.com | 1999 | Rogers, United States | 1 | A range of EP diagnostic and ablation catheters is developed. |
Detailed competitors of Bolt Med
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Bolt Med
The website of Bolt Med (boltmed.com) receives about 3.6K visits a month.
- Monthly visits3.6K
▲ 75.8% vs previous month
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Bolt Med (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bolt Med
Complete news archive for Bolt Med
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bolt Med
Bolt Med was founded in 2019.
Bolt Med is headquartered in Carlsbad, United States. It is registered at Carlsbad, California, United States.
Keegan Harper is the CEO of Bolt Med, as recorded in our data. They have also founded this company.
Bolt Medical was founded in 2019 and is headquartered in Carlsbad, United States. Operations center on the medical device sector, where laser-based intravascular lithotripsy catheters are designed and developed. These systems target coronary and peripheral interventional procedures for patients with moderate to severe calcified arterial disease. Focus remains on advancing treatments for cardiovascular conditions through specialized catheter technology.
Bolt Med's top competitors include Instylla, Jupiter Endovascular and Access Point Technologies.
Bolt Med offers Bolt IVL.
Bolt Med has 1 investor. Key investors include Boston Scientific.
Yes. Bolt Med was acquired by Boston Scientific in January 2025.